loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Regadenoson

Menu
$ API Ref.Price (USD/KG) : 4,548,904Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2ASTELLAS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

REGADENOSON

US Patent Number : 8106183

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 22161

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-02-02

blank

02

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

REGADENOSON

US Patent Number : RE47301

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22161

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-02-02

blank